手机购彩

Hengrui Medicine always adheres to the development concept of “talent is the first resource”, continuously introduces high-level talents at home and abroad, gives full play to the leading role of high-end talents, makes every effort to create a talented place, and promotes the innovation and development of enterprises. The company currently has more than 3,000 R & D talents, including more than 2,000 doctors, masters and returnees.

Zhang Lianshan Deputy General Manager / Head of Global R & D

Chinese American, graduated from China Pharmaceutical University

PhD in Organic Chemistry, University of Tübingen, Germany

Postdoctoral Researcher, Department of Microbiology and Immunology, Vanderbilt University

Chief Research Scientist, Eli Lilly, 1998

2008 Senior Chemical Director of Marcadia Biotech, USA

Tao Weikang Deputy General Manager CEO of Shanghai Hengrui R & D Center

Chinese American, graduated from the Second Military Medical University

PhD in Molecular and Cell Biology from New Jersey Medical University

Postdoctoral Fellow at Princeton University

2000-2012 American Merck Pharmaceutical Company as a senior researcher

2012-2014 Vice President, Shanghai Ruizhi Chemical Research Co., Ltd.

Shen Yaping, Deputy General Manager

Canadian Chinese, graduated from Jinan University

Ph.D., University of Ottawa, Canada

1993-2004 Director of Medical Chemistry, Inflazyme Pharmaceuticals Inc, Canada

2004-2008 General Manager, Lippont Pharmaceuticals Inc, Canada

2008-2012 General Manager of Chemwerth Inc China